Injectable weight loss and diabetes therapies continue to thrive despite recent oral GLP-1 drug approvals. Experts said they ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

Explore the growing demand for GLP-1 weight-loss drugs shaped by online communities and consumer-driven choices outside ...

West Pharmaceutical Services reported better-than-expected quarterly earnings and revenue.

Amidst soaring demand for GLP-1 therapies, counterfeit Mounjaro injections worth Rs 70 lakh have been seized in Gurugram, ...

New IGD (Institute of Grocery Distribution) research reveals that uptake of GLP1 weight loss medications has almost doubled in the UK since June 2025, rising from 3.1% to 6% in March this year.

The acquisition of Kelonia Therapeutics, announced this week, is part of Lilly’s expansion into cancer treatments.

Hair loss is a potential side effect of weight loss medications, caused by a condition called telogen effluvium, which can be ...

Him & Hers announced Thursday that eligible users can now access the full r | Providers can now send prescriptions of Eli ...

Dietitian warns there are potential genetic influences that can change the way the body responds to weight-loss drugs ...

I’m a dietitian - this is why weight-loss jabs like Mounjaro or Wegovy might not work well for everyone - There are potential ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?